Biochemical profile of risperidone, a new antipsychotic.
about
Olanzapine treatment of adolescent rats causes enduring specific memory impairments and alters cortical development and function.A case of risperidone overdose in early schizophrenia: a review of potential complications.Risperidone versus haloperidol in acute and transient psychotic disorder.Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study.Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia, before and after antipsychotic treatment.Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D6*10/*10Clinical pharmacology of atypical antipsychotics: an update.Restricted usefulness of tetraethylammonium and 4-aminopyridine for the characterization of receptor-operated K+-channels.Transporter-mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target.Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypesRelationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.The relaxant 5-HT receptor in the dog coronary artery smooth muscle: pharmacological resemblance to the cloned 5-ht7 receptor subtype.Population pharmacokinetic modeling of risperidone and 9-hydroxyrisperidone to estimate CYP2D6 subpopulations in children and adolescents.Risperidone-associated adverse drug reactions and CYP2D6 polymorphisms in a South African cohort.Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE studyPediatric Traumatic Brain Injury and Autism: Elucidating Shared Mechanisms.Differential effects of various typical and atypical antipsychotics on plasma glucose and insulin levels in the mouse: evidence for the involvement of sympathetic regulation.Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutationMechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.Development of Risperidone PLGA Microspheres.Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats.Risperidone for schizophrenia.Schizophrenia: synthetic strategies and recent advances in drug design
P2860
Q27313333-EA444D8E-95E0-4A4E-9B1B-7B4098048AA4Q33922149-B7036FA0-B43C-4060-9FD2-B6B0969F8017Q34218304-BE7481CF-AB8D-491D-A9E1-80973CE67162Q34424124-702B4380-1A2D-4453-ADB4-9E8E8092AABDQ34574728-AD5073C7-C838-408C-99E6-746BEFCACD8BQ35287206-5BA9799B-FE53-4BDE-91F2-88508045811DQ35728228-80F08734-1EC3-45A9-98D3-AEC71B5EA0FEQ35756751-DBCDD398-77EA-43C8-99E4-3C6C1983F2DBQ35761679-57959A30-BE2B-4A96-9A44-C564A1AC7690Q35826139-44A13C82-EB07-4489-B65C-506CB8827EBBQ35847706-3281BC51-6A39-4CB4-BC41-28FFDB340716Q35873755-FF176303-98CF-4434-A9BE-6687B82650D2Q36233555-B14471DC-9C34-413C-B71D-CE6247701254Q36556433-F0640C00-68C6-4063-A335-2053B883D933Q37142429-4E7B7C4E-8585-4FF5-8E70-1025042564FFQ39028166-C6D59D27-8C93-4641-BB09-1ED73C07CF39Q39436079-4E93A05D-A777-46E2-9FB2-0D6F5970A2B2Q41578551-AD0958B2-30C8-41B9-992D-42E410058F08Q41846717-5CACD2F2-69B6-4768-8690-0B3F3D28D4D8Q41962765-5D4F68ED-DE2D-4F2F-9666-7A2DE5F0DD22Q42185986-3C603B8D-6396-451E-88E9-8019BBFF843BQ42581589-12F6B3A8-FD57-4BEB-A6FB-CF58866EF767Q57393544-D96EAA7C-B639-4A1C-BAD1-5DAB8A3F7344
P2860
Biochemical profile of risperidone, a new antipsychotic.
description
1988 nî lūn-bûn
@nan
1988 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
name
Biochemical profile of risperidone, a new antipsychotic.
@ast
Biochemical profile of risperidone, a new antipsychotic.
@en
Biochemical profile of risperidone, a new antipsychotic.
@nl
type
label
Biochemical profile of risperidone, a new antipsychotic.
@ast
Biochemical profile of risperidone, a new antipsychotic.
@en
Biochemical profile of risperidone, a new antipsychotic.
@nl
prefLabel
Biochemical profile of risperidone, a new antipsychotic.
@ast
Biochemical profile of risperidone, a new antipsychotic.
@en
Biochemical profile of risperidone, a new antipsychotic.
@nl
P2093
P1476
Biochemical profile of risperidone, a new antipsychotic.
@en
P2093
Gommeren W
Janssen PA
de Chaffoy de Courcelles D
P304
P407
P577
1988-11-01T00:00:00Z